| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/01/2006 | EP1462451B1 Novel crystalline forms of meloxicam and the preparation and interconversion methods thereof |
| 03/01/2006 | EP1392292B1 Pyranoindazoles and their use for the treatment of glaucoma |
| 03/01/2006 | EP1363910B1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 03/01/2006 | EP1347971B1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 03/01/2006 | EP1345942B1 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
| 03/01/2006 | EP1339710B1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 03/01/2006 | EP1339399B1 Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
| 03/01/2006 | EP1333823A4 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis |
| 03/01/2006 | EP1324774B1 Use of a ppar delta activator for treating inflammatory conditions |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1311672B1 tRNA-derived inhibitors of HIV reverse transcriptase |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1307192B1 Candesartan for treating migraine |
| 03/01/2006 | EP1268423B1 Indole derivatives as mcp-1 receptor antagonists |
| 03/01/2006 | EP1244433B1 Use of non-human SHIP2 knock-out mammals |
| 03/01/2006 | EP1206471B1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/01/2006 | EP1183033B1 Pyrrolotriazine inhibitors of kinases |
| 03/01/2006 | EP1105409B1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 03/01/2006 | EP1098638B1 Use of a glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 03/01/2006 | EP1092035B1 Targeted integration into chromosomes using retroviral vectors |
| 03/01/2006 | EP1086105B1 Fused azepinone cyclin dependent kinase inhibitors |
| 03/01/2006 | EP1037616B1 COMBINATION OF ALPHA-1-ADRENERGIC ANTAGONISTS AND A CGMP PDEv INHIBITOR FOR THE TREATMENT OF IMPOTENCE |
| 03/01/2006 | EP0998569B1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
| 03/01/2006 | EP0944311B1 Method for antagonizing HEREGUlin or its receptor and use for the inhibition of cancer cells |
| 03/01/2006 | EP0933380B1 Method of searching for physiologically active substances and process for producing the same |
| 03/01/2006 | EP0932678B1 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/01/2006 | EP0783526B1 Growth blocking agents to the vitamin b12 binding sites on transcobalamin ii |
| 03/01/2006 | EP0750507B2 Proteasome regulation of nf-kappa-b activity |
| 03/01/2006 | CN1741984A CaSR antagonist |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741798A Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia |
| 03/01/2006 | CN1740182A Novel bisamidate phosphonate prodrugs |
| 03/01/2006 | CN1739800A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 03/01/2006 | CN1739793A Human granulocyte-macrophage colony stimulating factor spray and its prepn process |
| 03/01/2006 | CN1739782A Health medicated wine for scraping sha-syndrome and cupping |
| 03/01/2006 | CN1739744A Production process of flavone compound powder |
| 03/01/2006 | CN1739668A Transaminase lowering dripping pill and its prepn |
| 03/01/2006 | CN1739653A Chinese medicine prepn for soothing the liver and alleviating mental depression and its prepn process and quality control method |
| 03/01/2006 | CN1739611A Stasis relieving oral liquid for treating rhinitis and its prepn |
| 03/01/2006 | CN1739579A Chinese medicine prepn for removing blood stasis and activating blood circulation to dissipate blood stasis and its prepn process |
| 03/01/2006 | CN1739576A Active hair gel |
| 03/01/2006 | CN1739518A Application of penehyclidine hydrochloride in preparing medicine |
| 03/01/2006 | CN1739511A Application of penehyliclidine hydrochloride in preparing medicine |
| 03/01/2006 | CN1739496A Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders |
| 03/01/2006 | CN1243770C Neurotrophic growth factor |
| 03/01/2006 | CN1243747C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
| 03/01/2006 | CN1243746C Heterocyclic compound inhibiting angiogenesis |
| 03/01/2006 | CN1243741C Quinolinyl and benzothiazolyc PPAR-gamma modulators |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 03/01/2006 | CN1243723C N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 03/01/2006 | CN1243566C Car sickness preventing beverage |
| 03/01/2006 | CN1243550C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol and use thereof |
| 03/01/2006 | CN1243545C DNA-cleaving antitumor agents |
| 03/01/2006 | CN1243541C 2-(alpha-hydroxypentyl) benzoate and its preparing process and usage |
| 03/01/2006 | CN1243537C Use of composition containing at least one oxidative sensitive hydrophilic active ingredient through at least one maleic anhydride copolymer stabilization at cosmetic and /or skin |
| 02/28/2006 | US7005553 such as 2-nitrophenol by reacting 3-hydroxy-4-methoxybenzophenone with alkyl nitrate in presence of regioselective acid catalyst (sulfuric acid) |
| 02/28/2006 | US7005509 Pancreatic expressed chemokines, (PANEC-1); expression vectors, host cells, and diagnostic tests using probes for physiologic or pathologic compromise of the pancreas |
| 02/28/2006 | US7005500 Nucleotide sequence coding polypeptide for use in the diagnosis of of neoplastic disorders |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/28/2006 | US7005438 Pharmaceutically active isoindoline derivatives |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005434 Compounds and uses thereof |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005425 Administering a minimal dose of an Al adenosine receptor agonist in conjunction with a minimal dose of a beta blocker, calcium channel blocker, or cardiac glycoside |
| 02/28/2006 | US7005415 Wherein the DNA synthesis promoting activity of the heparin-binding protein is increased by the covalently bonded sugar chain which can be heparan sulfate; improved in vivo stabilities such as acid resistance and alkali resistance |
| 02/28/2006 | US7005122 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 02/28/2006 | US7005121 Arerosol; heating drug, vaporization, cooling |
| 02/28/2006 | US7004945 Devices and methods for the restoration of a spinal disc |
| 02/28/2006 | CA2373117C 13-methyl-erythromycin derivatives |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | WO2006020403A2 3-halo-2-oxopropionate salts and esters as novel anticancer agents |
| 02/23/2006 | WO2006019037A1 Method of judging liver fibrosis stage |
| 02/23/2006 | WO2006018998A1 Method of constructing clone mammal |
| 02/23/2006 | WO2006018418A2 Antiangiogenic peptides |
| 02/23/2006 | WO2005069771A3 Small molecule antagonists of bcl-2 family proteins |
| 02/23/2006 | WO2005061538A3 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 02/23/2006 | US20060041164 liver X receptor LXR agonists; increasing ABCA1, ABCG1, and apolipoprotein E expression, increasing cholesterol efflux from peripheral cells, cardiovascular disease, inflammation; 2-(3-{3-[[2-Chloro-3-(trifluoromethyl)benzyl](2,2-diphenylethyl)amino]-2-methyl-propoxy}-phenyl)acetic acid methyl ester |
| 02/23/2006 | US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 02/23/2006 | US20060041138 Process for producing paroxetine hydrochloride hydrate |
| 02/23/2006 | US20060041130 Syntheses of quinazolinones |
| 02/23/2006 | US20060041014 Treatment of male sexual dysfunction |
| 02/23/2006 | US20060041001 Useful in the treatment of diseases or conditions susceptible to adrenergic regulation controlled by alpha-2 adrenergic receptors |
| 02/23/2006 | US20060040986 Erythropoietin production accelerator |
| 02/23/2006 | US20060040979 3-Aryl-2-hydroxypropionic acid derivative I |
| 02/23/2006 | US20060040972 Pyrazolonaphthyridine derivative |
| 02/23/2006 | US20060040969 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 |
| 02/23/2006 | US20060040964 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders |
| 02/23/2006 | US20060040963 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/23/2006 | US20060040957 Bicyclic pyrimidine matrix metalloproteinase inhibitors |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040907 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 02/23/2006 | US20060040891 Lipid a and other carbohydrate ligand analogs |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040850 Use of enzyme inhibitors with aminopeptidase n and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states |
| 02/23/2006 | US20060040331 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 02/23/2006 | US20060040324 Methods for making metallopeptides and metallopeptide libraries |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040312 Uses of kappa-conotoxin PVIIA |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |